CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: mestranol
Accession: CHEBI:6784
browse the term
Definition: A terminal acetylenic compound that is (17alpha)-17-ethynylestra-1(10),2,4-triene substituted by a methoxy group at position 3 and a hydroxy group at position 17.
Synonyms: exact_synonym: 17-ethynyl-3-methoxyestra-1(10),2,4-trien-17beta-ol
related_synonym: (+)-17alpha-Ethynyl-17beta-hydroxy-3-methoxy-1,3,5(10)-estratriene; (+)-17alpha-Ethynyl-17beta-hydroxy-3-methoxy-1,3,5(10)-oestratriene; 17-ethynyl-3-methoxyoestra-1(10),2,4-trien-17beta-ol; 3-Methoxy-17alpha-ethynylestradiol; 3-Methoxy-19-norpregna-1,3,5(10)-trien-20-yn-17beta-ol; Ethynylestradiol 3-methyl ether; Formula=C21H26O2; InChI=1S/C21H26O2/c1-4-21(22)12-10-19-18-7-5-14-13-15(23-3)6-8-16(14)17(18)9-11-20(19,21)2/h1,6,8,13,17-19,22H,5,7,9-12H2,2-3H3/t17-,18-,19+,20+,21+/m1/s1; InChIKey=IMSSROKUHAOUJS-MJCUULBUSA-N; SMILES=[H][C@]12CC[C@@]3(C)[C@@]([H])(CC[C@@]3(O)C#C)[C@]1([H])CCc1cc(OC)ccc21; mestranolum
xref: Beilstein:2625905; CAS:72-33-3; DrugBank:DB01357; Drug_Central:1714; HMDB:HMDB0015446; KEGG:C07618; KEGG:D00575; LINCS:LSM-2693
xref_mesh: MESH:D008656
xref: PMID:12139060; PMID:16414683; Patent:US2666769; Reaxys:2625905; Wikipedia:Mestranol
G
Abhd2
abhydrolase domain containing 2, acylglycerol lipase
increases expression
ISO
Mestranol results in increased expression of ABHD2 mRNA
CTD
PMID:26865669
NCBI chr 1:133,217,403...133,298,564
Ensembl chr 1:133,217,375...133,299,061
G
Afp
alpha-fetoprotein
affects binding
EXP
Mestranol binds to AFP protein
CTD
PMID:23013281 PMID:25349334
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Alad
aminolevulinate dehydratase
decreases expression
ISO
Mestranol results in decreased expression of ALAD mRNA
CTD
PMID:26865669
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
G
Ar
androgen receptor
multiple interactions decreases expression
ISO
Mestranol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein] Mestranol results in decreased expression of AR mRNA
CTD
PMID:33049310 PMID:36098747
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Areg
amphiregulin
increases expression
ISO
Mestranol results in increased expression of AREG mRNA
CTD
PMID:26865669
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
G
Car12
carbonic anhydrase 12
increases expression
ISO
Mestranol results in increased expression of CA12 mRNA
CTD
PMID:26865669
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
G
Ccnd1
cyclin D1
increases expression
ISO
Mestranol results in increased expression of CCND1 mRNA
CTD
PMID:26865669
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccng2
cyclin G2
decreases expression
ISO
Mestranol results in decreased expression of CCNG2 mRNA
CTD
PMID:26865669
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
G
Cd44
CD44 molecule
increases expression
ISO
Mestranol results in increased expression of CD44 mRNA
CTD
PMID:26865669
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Clmn
calmin
decreases expression
ISO
Mestranol results in decreased expression of CLMN mRNA
CTD
PMID:26865669
NCBI chr 6:123,707,710...123,807,283
Ensembl chr 6:123,713,507...123,807,272
G
Cxcl12
C-X-C motif chemokine ligand 12
increases expression
ISO
Mestranol results in increased expression of CXCL12 mRNA
CTD
PMID:26865669
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
decreases expression
ISO
Mestranol results in decreased expression of CYP17A1 mRNA
CTD
PMID:36098747
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
increases expression
ISO
Mestranol results in increased expression of CYP19A1 mRNA
CTD
PMID:36098747
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Dmc1
DNA meiotic recombinase 1
decreases expression
ISO
Mestranol results in decreased expression of DMC1 mRNA
CTD
PMID:36098747
NCBI chr 7:111,124,888...111,167,465
Ensembl chr 7:111,124,888...111,167,952
G
Dyrk2
dual specificity tyrosine phosphorylation regulated kinase 2
decreases expression
ISO
Mestranol results in decreased expression of DYRK2 mRNA
CTD
PMID:26865669
NCBI chr 7:54,348,724...54,381,363
Ensembl chr 7:54,349,610...54,380,106
G
Efna1
ephrin A1
decreases expression
ISO
Mestranol results in decreased expression of EFNA1 mRNA
CTD
PMID:26865669
NCBI chr 2:174,681,676...174,689,061
Ensembl chr 2:174,681,682...174,690,866
G
Egf
epidermal growth factor
multiple interactions
EXP
[EGF protein co-treated with Mestranol] results in increased expression of MYC mRNA
CTD
PMID:12632255
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Egr3
early growth response 3
increases expression
ISO
Mestranol results in increased expression of EGR3 mRNA
CTD
PMID:26865669
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627
G
Epha4
Eph receptor A4
decreases expression
ISO
Mestranol results in decreased expression of EPHA4 mRNA
CTD
PMID:26865669
NCBI chr 9:78,815,460...78,958,139
Ensembl chr 9:78,815,460...78,958,139
G
Esr1
estrogen receptor 1
increases activity multiple interactions
ISO
Mestranol results in increased activity of ESR1 protein ESR1 protein affects the reaction [Mestranol results in increased expression of GREB1 mRNA]; ESR1 protein affects the reaction [Mestranol results in increased expression of SGK1 mRNA]; Mestranol binds to and results in increased activity of ESR1 protein
CTD
PMID:12623674 PMID:26865669 PMID:33049310 PMID:33405908
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
affects binding multiple interactions increases expression
ISO
Mestranol binds to ESR2 protein Mestranol binds to and results in increased activity of ESR2 protein Mestranol results in increased expression of ESR2 mRNA
CTD
PMID:12224631 PMID:33049310 PMID:36098747
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
F7
coagulation factor VII
increases expression
ISO
Mestranol results in increased expression of F7 protein
CTD
PMID:614942
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
G
Fhl2
four and a half LIM domains 2
increases expression
ISO
Mestranol results in increased expression of FHL2 mRNA
CTD
PMID:26865669
NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:45,388,981...45,431,192
G
Foxc1
forkhead box C1
increases expression
ISO
Mestranol results in increased expression of FOXC1 mRNA
CTD
PMID:26865669
NCBI chr17:32,631,379...32,635,361
Ensembl chr17:32,633,142...32,634,803
G
Foxl2
forkhead box L2
increases expression
ISO
Mestranol results in increased expression of FOXL2 mRNA
CTD
PMID:36098747
NCBI chr 8:99,512,971...99,514,500
Ensembl chr 8:99,513,303...99,514,427
G
Fshb
follicle stimulating hormone subunit beta
decreases expression
ISO
Mestranol results in decreased expression of FSHB protein
CTD
PMID:36098747
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
G
Fshr
follicle stimulating hormone receptor
decreases expression
ISO
Mestranol results in decreased expression of FSHR mRNA
CTD
PMID:36098747
NCBI chr 6:5,198,825...5,406,785
Ensembl chr 6:5,198,825...5,406,785
G
Gper1
G protein-coupled estrogen receptor 1
increases expression
ISO
Mestranol results in increased expression of GPER1 protein
CTD
PMID:36098747
NCBI chr12:15,217,217...15,222,679
Ensembl chr12:15,217,442...15,221,889
G
Greb1
growth regulating estrogen receptor binding 1
multiple interactions increases expression
ISO
ESR1 protein affects the reaction [Mestranol results in increased expression of GREB1 mRNA]
CTD
PMID:33405908
NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633
G
H2ax
H2A.X variant histone
decreases expression multiple interactions
ISO
Mestranol results in decreased expression of H2AX mRNA; Mestranol results in decreased expression of H2AX protein Fulvestrant inhibits the reaction [Mestranol results in decreased expression of H2AX protein]
CTD
PMID:36098747
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
Hsd3b1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
multiple interactions decreases expression
ISO
Fulvestrant inhibits the reaction [Mestranol results in decreased expression of HSD3B1 protein] Mestranol results in decreased expression of HSD3B1 mRNA; Mestranol results in decreased expression of HSD3B1 protein
CTD
PMID:36098747
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
G
Id3
inhibitor of DNA binding 3
decreases expression
ISO
Mestranol results in decreased expression of ID3 mRNA
CTD
PMID:26865669
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
G
Jak2
Janus kinase 2
increases expression
ISO
Mestranol results in increased expression of JAK2 mRNA
CTD
PMID:26865669
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Kynu
kynureninase
decreases expression
ISO
Mestranol results in decreased expression of KYNU mRNA
CTD
PMID:26865669
NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:27,778,772...27,929,488
G
Lhb
luteinizing hormone subunit beta
decreases expression
ISO
Mestranol results in decreased expression of LHB protein
CTD
PMID:36098747
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Mical2
microtubule associated monooxygenase, calponin and LIM domain containing 2
increases expression
ISO
Mestranol results in increased expression of MICAL2 mRNA
CTD
PMID:26865669
NCBI chr 1:166,345,853...166,530,575
Ensembl chr 1:166,345,859...166,471,719 Ensembl chr 1:166,345,859...166,471,719
G
Myb
MYB proto-oncogene, transcription factor
increases expression
ISO
Mestranol results in increased expression of MYB mRNA
CTD
PMID:26865669
NCBI chr 1:15,939,771...15,973,367
Ensembl chr 1:15,939,761...15,973,057
G
Mybl1
MYB proto-oncogene like 1
increases expression
ISO
Mestranol results in increased expression of MYBL1 mRNA
CTD
PMID:26865669
NCBI chr 5:9,582,905...9,618,179
Ensembl chr 5:9,582,934...9,618,183
G
Myc
MYC proto-oncogene, bHLH transcription factor
multiple interactions
EXP
[EGF protein co-treated with Mestranol] results in increased expression of MYC mRNA
CTD
PMID:12632255
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nmrk1
nicotinamide riboside kinase 1
increases expression
ISO
Mestranol results in increased expression of NMRK1 mRNA
CTD
PMID:26865669
NCBI chr 1:216,049,350...216,076,792
Ensembl chr 1:216,049,437...216,076,791
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
Mestranol binds to and results in increased activity of NR1I2 protein
CTD
PMID:33049310
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Olfm1
olfactomedin 1
increases expression
ISO
Mestranol results in increased expression of OLFM1 mRNA
CTD
PMID:26865669
NCBI chr 3:11,520,522...11,558,240
Ensembl chr 3:11,520,729...11,558,239
G
Pdzk1
PDZ domain containing 1
increases expression
ISO
Mestranol results in increased expression of PDZK1 mRNA
CTD
PMID:26865669
NCBI chr 2:184,376,161...184,407,514
Ensembl chr 2:184,376,161...184,407,514
G
Pgr
progesterone receptor
increases expression
ISO
Mestranol results in increased expression of PGR mRNA
CTD
PMID:26865669
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Pik3r3
phosphoinositide-3-kinase regulatory subunit 3
decreases expression
ISO
Mestranol results in decreased expression of PIK3R3 mRNA
CTD
PMID:26865669
NCBI chr 5:129,700,925...129,772,591
Ensembl chr 5:129,701,229...129,772,583
G
Plaur
plasminogen activator, urokinase receptor
increases expression
ISO
Mestranol results in increased expression of PLAUR mRNA
CTD
PMID:26865669
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
G
Plekhf2
pleckstrin homology and FYVE domain containing 2
decreases expression
ISO
Mestranol results in decreased expression of PLEKHF2 mRNA
CTD
PMID:26865669
NCBI chr 5:24,091,077...24,106,758
Ensembl chr 5:24,090,688...24,106,601
G
Pou5f2
POU domain class 5, transcription factor 2
decreases expression
ISO
Mestranol results in decreased expression of POU5F2 mRNA
CTD
PMID:36098747
NCBI chr 2:7,907,504...7,908,738
G
Prss23
serine protease 23
increases expression
ISO
Mestranol results in increased expression of PRSS23 mRNA
CTD
PMID:26865669
NCBI chr 1:143,402,725...143,422,182
Ensembl chr 1:143,401,396...143,422,091
G
Ptges
prostaglandin E synthase
increases expression
ISO
Mestranol results in increased expression of PTGES mRNA
CTD
PMID:26865669
NCBI chr 3:14,177,892...14,189,236
G
Rapgefl1
Rap guanine nucleotide exchange factor like 1
increases expression
ISO
Mestranol results in increased expression of RAPGEFL1 mRNA
CTD
PMID:26865669
NCBI chr10:83,793,711...83,810,373
Ensembl chr10:83,793,694...83,810,371
G
Rbbp8
RB binding protein 8, endonuclease
increases expression
ISO
Mestranol results in increased expression of RBBP8 mRNA
CTD
PMID:26865669
NCBI chr18:2,922,985...2,988,851
Ensembl chr18:2,921,286...2,988,846
G
Rcl1
RNA terminal phosphate cyclase-like 1
increases expression
ISO
Mestranol results in increased expression of RCL1 mRNA
CTD
PMID:26865669
NCBI chr 1:226,824,561...226,869,046
Ensembl chr 1:226,824,534...226,902,315
G
Ret
ret proto-oncogene
increases expression
ISO
Mestranol results in increased expression of RET mRNA
CTD
PMID:26865669
NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:151,326,431...151,368,176
G
Rhbdf1
rhomboid 5 homolog 1
decreases expression
ISO
Mestranol results in decreased expression of RHBDF1 mRNA
CTD
PMID:26865669
NCBI chr10:15,406,832...15,419,765
Ensembl chr10:15,406,859...15,419,763
G
Rspo1
R-spondin 1
increases expression
ISO
Mestranol results in increased expression of RSPO1 mRNA
CTD
PMID:36098747
NCBI chr 5:137,251,629...137,273,273
Ensembl chr 5:137,251,659...137,272,933
G
Sgk1
serum/glucocorticoid regulated kinase 1
increases expression multiple interactions
ISO
Mestranol results in increased expression of SGK1 mRNA ESR1 protein affects the reaction [Mestranol results in increased expression of SGK1 mRNA]
CTD
PMID:26865669 PMID:33405908
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
G
Sgk3
serum/glucocorticoid regulated kinase family, member 3
increases expression
ISO
Mestranol results in increased expression of SGK3 mRNA
CTD
PMID:26865669
NCBI chr 5:9,345,761...9,472,243
Ensembl chr 5:9,346,040...9,415,476
G
Siah2
siah E3 ubiquitin protein ligase 2
increases expression
ISO
Mestranol results in increased expression of SIAH2 mRNA
CTD
PMID:26865669
NCBI chr 2:142,913,924...142,931,752
Ensembl chr 2:142,914,003...142,931,950
G
Slc7a5
solute carrier family 7 member 5
increases expression
ISO
Mestranol results in increased expression of SLC7A5 mRNA
CTD
PMID:26865669
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
G
Smox
spermine oxidase
increases expression
ISO
Mestranol results in increased expression of SMOX mRNA
CTD
PMID:26865669
NCBI chr 3:118,731,814...118,767,242
Ensembl chr 3:118,731,900...118,765,710
G
Ssbp2
single-stranded DNA binding protein 2
decreases expression
ISO
Mestranol results in decreased expression of SSBP2 mRNA
CTD
PMID:26865669
NCBI chr 2:22,650,488...22,938,669
Ensembl chr 2:22,651,258...22,933,696
G
Svil
supervillin
increases expression
ISO
Mestranol results in increased expression of SVIL mRNA
CTD
PMID:26865669
NCBI chr17:52,648,502...52,844,114
Ensembl chr17:52,648,502...52,793,404
G
Sycp3
synaptonemal complex protein 3
decreases expression
ISO
Mestranol results in decreased expression of SYCP3 mRNA; Mestranol results in decreased expression of SYCP3 protein
CTD
PMID:36098747
NCBI chr 7:22,874,055...22,888,512
Ensembl chr 7:22,874,055...22,888,511
G
Tfap2a
transcription factor AP-2 alpha
decreases expression
ISO
Mestranol results in decreased expression of TFAP2A mRNA
CTD
PMID:26865669
NCBI chr17:24,028,716...24,047,507
Ensembl chr17:24,024,432...24,047,507
G
Tfap2c
transcription factor AP-2 gamma
increases expression
ISO
Mestranol results in increased expression of TFAP2C mRNA
CTD
PMID:26865669
NCBI chr 3:161,315,114...161,322,998
Ensembl chr 3:161,315,031...161,322,995
G
Tfpi
tissue factor pathway inhibitor
decreases expression
ISO
Mestranol results in decreased expression of TFPI mRNA
CTD
PMID:26865669
NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880
G
Thrb
thyroid hormone receptor beta
multiple interactions
ISO
Mestranol binds to and results in increased activity of THRB protein
CTD
PMID:33049310
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
G
Wwc1
WW and C2 domain containing 1
increases expression
ISO
Mestranol results in increased expression of WWC1 mRNA
CTD
PMID:26865669
NCBI chr10:20,300,735...20,454,393
Ensembl chr10:20,300,833...20,454,497
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all